Skip to main navigation Skip to search Skip to main content

Monoclonal RhD prophylaxis: high time to evaluate efficacy: high time to evaluate efficacy

  • E. J.T. Verweij
  • , Abera Tura
  • , Tadesse Gure
  • , Jeremia Pyuza
  • , Bariki Mchome
  • , Kondwani Kawaza
  • , Peter Moons
  • , Derek de Winter
  • , Renske van't Oever
  • , Steven Spitalnik
  • , C. Ellen van der Schoot
  • , Thomas van den Akker
  • Leiden University
  • Haramaya University
  • Kilimanjaro Christian Medical Centre
  • Kamuzu University of Health Sciences
  • WIRhE
  • Columbia University
  • WIRhE
  • Sanquin Blood Supply Foundation
  • Vrije Universiteit Amsterdam

Research output: Contribution to journalLetterpeer-review

12 Citations (Scopus)
Original languageEnglish
Pages (from-to)806-807
Number of pages2
JournalThe Lancet
Volume403
Issue number10429
DOIs
Publication statusPublished - 2 Mar 2024
Externally publishedYes

Cite this